Causes, consequences, and treatment of osteoporosis in men

Jameela Banu

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Men undergo gradual bone loss with aging, resulting in fragile bones. It is estimated that one in five men will suffer an osteoporotic fracture during their lifetime. The prognosis for men after a hip fracture is very grim. A major cause is reduction of free testosterone. Many other factors result in secondary osteoporosis, including treatment for other diseases such as cancer and diabetes. Patients should be screened not only for bone density but also assessed for their nutritional status, physical activity, and drug intake. Therapy should be chosen based on the type of osteoporosis. Available therapies include testosterone replacement, bisphosphonates, and nutritional supplementation with calcium, vitamin D, fatty acids, and isoflavones, as well as certain specific antibodies, like denosumab and odanacatib, and inhibitors of certain proteins.

Original languageEnglish (US)
Pages (from-to)849-860
Number of pages12
JournalDrug Design, Development and Therapy
Volume7
DOIs
StatePublished - Aug 21 2013
Externally publishedYes

Fingerprint

Osteoporosis
Testosterone
Bone and Bones
Osteoporotic Fractures
Isoflavones
Hip Fractures
Diphosphonates
Nutritional Status
Vitamin D
Bone Density
Fatty Acids
Therapeutics
Exercise
Calcium
Antibodies
Pharmaceutical Preparations
Neoplasms
Proteins
Denosumab
odanacatib

Keywords

  • Antibodies
  • Bisphosphonates
  • Hormones
  • Male osteoporosis
  • Nutritional supplements
  • Protein inhibitors
  • Risk factors

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology
  • Drug Discovery

Cite this

Causes, consequences, and treatment of osteoporosis in men. / Banu, Jameela.

In: Drug Design, Development and Therapy, Vol. 7, 21.08.2013, p. 849-860.

Research output: Contribution to journalArticle

@article{d28f555a54f04e6fbc38a606ab7e5dd3,
title = "Causes, consequences, and treatment of osteoporosis in men",
abstract = "Men undergo gradual bone loss with aging, resulting in fragile bones. It is estimated that one in five men will suffer an osteoporotic fracture during their lifetime. The prognosis for men after a hip fracture is very grim. A major cause is reduction of free testosterone. Many other factors result in secondary osteoporosis, including treatment for other diseases such as cancer and diabetes. Patients should be screened not only for bone density but also assessed for their nutritional status, physical activity, and drug intake. Therapy should be chosen based on the type of osteoporosis. Available therapies include testosterone replacement, bisphosphonates, and nutritional supplementation with calcium, vitamin D, fatty acids, and isoflavones, as well as certain specific antibodies, like denosumab and odanacatib, and inhibitors of certain proteins.",
keywords = "Antibodies, Bisphosphonates, Hormones, Male osteoporosis, Nutritional supplements, Protein inhibitors, Risk factors",
author = "Jameela Banu",
year = "2013",
month = "8",
day = "21",
doi = "10.2147/DDDT.S46101",
language = "English (US)",
volume = "7",
pages = "849--860",
journal = "Drug Design, Development and Therapy",
issn = "1177-8881",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Causes, consequences, and treatment of osteoporosis in men

AU - Banu, Jameela

PY - 2013/8/21

Y1 - 2013/8/21

N2 - Men undergo gradual bone loss with aging, resulting in fragile bones. It is estimated that one in five men will suffer an osteoporotic fracture during their lifetime. The prognosis for men after a hip fracture is very grim. A major cause is reduction of free testosterone. Many other factors result in secondary osteoporosis, including treatment for other diseases such as cancer and diabetes. Patients should be screened not only for bone density but also assessed for their nutritional status, physical activity, and drug intake. Therapy should be chosen based on the type of osteoporosis. Available therapies include testosterone replacement, bisphosphonates, and nutritional supplementation with calcium, vitamin D, fatty acids, and isoflavones, as well as certain specific antibodies, like denosumab and odanacatib, and inhibitors of certain proteins.

AB - Men undergo gradual bone loss with aging, resulting in fragile bones. It is estimated that one in five men will suffer an osteoporotic fracture during their lifetime. The prognosis for men after a hip fracture is very grim. A major cause is reduction of free testosterone. Many other factors result in secondary osteoporosis, including treatment for other diseases such as cancer and diabetes. Patients should be screened not only for bone density but also assessed for their nutritional status, physical activity, and drug intake. Therapy should be chosen based on the type of osteoporosis. Available therapies include testosterone replacement, bisphosphonates, and nutritional supplementation with calcium, vitamin D, fatty acids, and isoflavones, as well as certain specific antibodies, like denosumab and odanacatib, and inhibitors of certain proteins.

KW - Antibodies

KW - Bisphosphonates

KW - Hormones

KW - Male osteoporosis

KW - Nutritional supplements

KW - Protein inhibitors

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=84882790066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882790066&partnerID=8YFLogxK

U2 - 10.2147/DDDT.S46101

DO - 10.2147/DDDT.S46101

M3 - Article

C2 - 24009413

AN - SCOPUS:84882790066

VL - 7

SP - 849

EP - 860

JO - Drug Design, Development and Therapy

JF - Drug Design, Development and Therapy

SN - 1177-8881

ER -